International Veterinary Sciences Appoints CEO and General Partner
International Veterinary Sciences (IVS), a developer and manufacturer of quality pet care products that promote pet health and wellness in Anaheim, Calif., has appointed Arthur Bedrosian as CEO and Partner.
Bedrosian comes to IVS after running several successful businesses over the past 30 years, according to the company.
Most recently, he served as CEO of publicly traded Lannett Co., a generic pharmaceutical company where he led significant business growth on behalf of Lannett Company, Inc. from $10 million in fiscal 2000 to $700 million by fiscal 2018, said company officials. Complementing Lannett’s organic growth with several strategic acquisitions, Bedrosian expanded Lannett's global reach and helped secure over 50 FDA abbreviated and one new drug approval during his tenure. He has experience in supplying veterinary prescription drugs to the veterinary market.
In his new role as CEO of IVS, Bedrosian will be focused on growing the IVS business both domestically and internationally. He will continue to build the over-the-counter pet supplement brand and lead efforts to create a new line of veterinary pharmaceutical products, while leveraging his extensive experience in manufacturing, licensing and FDA compliance.